Argenx
ARGX
#433
Rank
ยฃ43.85 B
Marketcap
ยฃ701.75
Share price
1.67%
Change (1 day)
74.80%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of December 2025 : ยฃ35.67 Million

According to Argenx 's latest financial reports the company's total debt is ยฃ35.67 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2024-12-31ยฃ31.12 M98.24%
2023-12-31ยฃ15.69 M52.84%
2022-12-31ยฃ10.27 M20.93%
2021-12-31ยฃ8.49 M19.89%
2020-12-31ยฃ7.08 M26.93%
2019-12-31ยฃ5.58 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31ยฃ1.83 M-0.05%
2011-12-31ยฃ1.83 M